1. Home
  2. OCSL vs ABCL Comparison

OCSL vs ABCL Comparison

Compare OCSL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oaktree Specialty Lending Corporation

OCSL

Oaktree Specialty Lending Corporation

HOLD

Current Price

$10.94

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.28

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCSL
ABCL
Founded
2007
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
OCSL
ABCL
Price
$10.94
$3.28
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$13.10
$7.75
AVG Volume (30 Days)
750.4K
2.6M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
14.36%
N/A
EPS Growth
N/A
10.91
EPS
0.06
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.31
$25.44
P/E Ratio
$186.17
N/A
Revenue Growth
N/A
160.56
52 Week Low
$10.63
$1.89
52 Week High
$15.63
$6.52

Technical Indicators

Market Signals
Indicator
OCSL
ABCL
Relative Strength Index (RSI) 38.92 41.68
Support Level $10.63 $2.75
Resistance Level $13.89 $3.84
Average True Range (ATR) 0.25 0.15
MACD 0.03 -0.02
Stochastic Oscillator 38.14 5.79

Price Performance

Historical Comparison
OCSL
ABCL

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: